With the retirement of Colorado’s color-coded COVID-19 restrictions dial, state and local leaders are today steering Colorado toward a pandemic off-ramp. Whether that succeeds or fails will depend mightily on a few more weeks of personal responsibility and restraint from a restrictions-fatigued population.
Hart Van Denburg/CPR News
During the COVID-19 pandemic, a sign on Berthoud Pass reminds travelers to wear a face mask, Thursday morning, Oct. 22, 2020.
Aaron Weiss was 72 hours away from getting his first dose of the coronavirus vaccine when it hit.
He started feeling tired. That soon turned into “textbook COVID,” complete with a hacking cough, extreme exhaustion and what Weiss called the “worst flu you ever had.”
“Just absolutely brutal,” Weiss said. “Aches. Night sweats. Just everything hurt for about a week there.”
He and his family had been super careful for a full year of the pandemic, working from home and avoiding close contact with others outside their family bubble. But that still wasn’t enough for the 43-year-old Littleton resident to avoid two trips to the ER and then a 5-day stay in the hospital.
Dr. Comilla Sasson said she lost three former colleagues to suicide in the past year. Author: Noel Brennan Updated: 7:22 PM MDT April 7, 2021
COLORADO, USA The emotional challenge of getting through the pandemic is weighing on the mental health of many health care workers.
A recent study from the University of Utah Health published in the Journal of Psychiatric Research suggested more than half of frontline health care workers involved in COVID-19 care could be at risk for one or more mental health problems.
“Probably like six weeks ago, I think I hit a wall, you know, where I kind of went, oh my gosh, OK, like I think I gotta just take a break, said Dr. Comilla Sasson.
It’s a closely held secret : Highly promising COVID-19 treatment hasn t gained widespread use Print this article
Monoclonal antibodies could considerably reduce the threat from the coronavirus as they have been found to reduce viral loads before infection becomes severe, something that other once-promising drugs such as hydroxychloroquine and ivermectin have failed to do.
Yet, although monoclonal antibodies were given emergency use authorization by the Food and Drug Administration in November, they were not widely used during the winter surge when thousands of people died. The therapy is still not a treatment in widespread use in much of the nation.